Virtual Education Series 2021

Registration is free to all who are interested, but all attendees must register to receive access information.

Attendees of the live webinar will receive a certificate of attendance at the conclusion of the series.

Recordings of Previous Sessions

Session Schedule

A final webinar for the 2021 series will be held on December 15.

11:00 AM U.S. Eastern Standard Time (EST, UTC-5)  =  5:00 PM Central European Time (CET)

Session 6

15 December 2021
11:00 AM EST

Register to Attend

Register by December 14.

Topic:  Agenesis of the corpus callosum

TALK 1:  Central nervous system anomalies: When should we be offering rapid exome sequencing? — Caitlin Baptiste, MD, Columbia University Medical Center — see publications
Dr. Baptiste will review the results of a study of trio exome sequencing in a large cohort of unselected fetuses with CNS anomalies. This study supports the importance of including whole exome sequencing in the workup of fetuses affected by CNS anomalies, even if the CNS anomaly is found in isolation.

TALK 2:  Callosal anomalies in the fetus — Karina Krajden Haratz, MD, MSc, Tel Aviv Sourasky Medical Center — see publications
Dr. Haratz will discuss the imaging features of callosal anomalies in the fetus and associated findings. Genetics and the challenge of predicting prognosis will be addressed as well.

   

The following time zone converter shows the equivalent webinar time for you, based on your computer clock.

Agenesis of the corpus callosum, 15 December 2021
Time converter at worldtimebuddy.com

 
Not on our mailing list? To receive updates about ISPD educational events, please log in to your account (or create an account) and update the Email Communication Preferences on your account page to include meeting announcements. (You do not have to be an ISPD member to have a basic account on our website.)
 


 
The Virtual Education Series has been supported by the ISPD Education Fund to which the ISPD Corporate Council member companies have made generous contributions. Learn More about the Corporate Council